XML 54 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation Outstanding Options and SSARs (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Options / SSARs outstanding at January 1, 2014 7,004,000lpx_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsOutstandingNumber  
Incentive shares granted 379,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod  
Options / SSARs exercised (107,000)lpx_StockIssuedDuringPeriodSharesStockOptionsAndSsarsExercised  
Options / SSARs canceled (267,000)lpx_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAndSsarsForfeituresAndExpirationsInPeriod  
Options / SSARs outstanding at September 30, 2014 7,009,000lpx_SharesBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsOutstandingNumber  
Options / SSARs outstanding Weighted Average Exercise Price $ 14.17lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsOutstandingWeightedAverageExercisePrice $ 14.19lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsOutstandingWeightedAverageExercisePrice
Options / SSARs granted Weighted Average Exercise Price $ 17.04lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardSsarsGrantsInPeriodWeightedAverageExercisePrice  
Options / SSARs exercised Weighted Average Exercise Price $ 11.37lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsExercisesInPeriodWeightedAverageExercisePrice  
Options / SSARs canceled Weighted Average Exercise Price $ 26.50lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice  
Options / SSARs outstanding Weighted Average Contractual Term (in years) 4 years 8 months 12 days  
Options / SSARs outstanding Aggregate Intrinsic Value (in millions) $ 31.8lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsOutstandingIntrinsicValue  
Vested and expected to vest 6,658,000lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsVestedAndExpectedToVestOutstandingNumber  
Vested and expected to vest Aggregate Intrinsic Value (in millions) 30.2lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue  
Options / SSARs exercisable 6,204,000lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsExercisableNumber  
Options / SSARs exercisable Weighted Average Exercise Price $ 13.44lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsExercisableWeightedAverageExercisePrice  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 4 years 1 month 6 days  
Options / SSARs exercisable Aggregate Intrinsic Value (in millions) 31.6lpx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndSsarsExercisableIntrinsicValue  
Options and SSARs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Weighted-average period of years costs are expected to be recognied over 1 year 10 months 24 days  
Compensation Expense 0.9us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= lpx_OptionsAndSsarsMember
 
Unrecognized compensation costs $ 6.7us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
/ us-gaap_AwardTypeAxis
= lpx_OptionsAndSsarsMember
 
Number of Shares Available for Grant 3,900,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
/ us-gaap_AwardTypeAxis
= lpx_OptionsAndSsarsMember
 
Stock Appreciation Rights (SARs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Vesting Period 3 years